Using Sapu Nano’s proprietary Deciparticle™ technology, Sapu-003 delivers everolimus intravenouslySYDNEY, Australia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – Sapu Nano today announced the ...
4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...
Apollo Therapeutics will inject capital and expertise into pipeline of potentially lifesaving medicines through an agreement with the University of Oxford. Collaboration highlights a shared strategic ...
EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6. The expansion cohort for pancreatic ductal ...
PTC Therapeutics gets $12 million cash up front, plus milestone and licensing payments from Roche.Biopharmaceutical company PTC Therapeutics Inc., in South Plainfield, said Wednesday it entered into a ...
Editor's Note: This story was featured in WBUR's weekly health newsletter, CommonHealth. If you like what you read and want it in your inbox, sign up here. One way artificial intelligence promises to ...
In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway. By Steve Lohr Photographs by Spencer Lowell ...
PITTSBURGH, Feb. 28, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Idorsia Ltd (SIX: IDIA) today announced they have entered into agreements for a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback